Standout Papers
Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
2020
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers
2009
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
2020
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease
2012
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response
2009
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Turning Hepatitis C into a Real Virus
2010 StandoutNobel
Is COVID-19 receiving ADE from other coronaviruses?
2020
In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus Δσ
2011
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Metazoan MicroRNAs
2018 Standout
Immune Responses to HCV and Other Hepatitis Viruses
2014
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
2011 StandoutNobel
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
2020
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
2013
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins
2010
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
2020
Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection
2016
Fabrication of flexible self-standing all-cellulose nanofibrous composite membranes for virus removal
2016 StandoutNobel
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
2021
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
2014
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
2015
Recombinant HCV Variants With NS5A From Genotypes 1–7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α
2010
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
2012
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
2020
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
SARS-CoV-2 vaccines in development
2020 StandoutNature
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Naked Viruses That Aren't Always Naked: Quasi-Enveloped Agents of Acute Hepatitis
2014
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains
2012
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
2012
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
2010
Rapid COVID-19 vaccine development
2020 Science
Evolution of a Cell Culture-Derived Genotype 1a Hepatitis C Virus (H77S.2) during Persistent Infection with Chronic Hepatitis in a Chimpanzee
2014
MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR
2011
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
On the History of Hepatitis C Virus Cell Culture Systems
2013
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
2021 Standout
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
2011
Prospects for a safe COVID-19 vaccine
2020
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system
2012
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Immune control and failure in HCV infection—tipping the balance
2014
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
2016
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
2010
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
2020 Standout
Works of Benoît Callendret being referenced
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
A siege of hepatitis: Immune boost for viral hepatitis
2011
T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee
2014
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein
2014
Selection-Driven Immune Escape Is Not A Significant Factor in the Failure of Cd4 T Cell Responses in Persistent Hepatitis C Virus Infection
2009
A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks
2016
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years
2020
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway
2011
902. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of a Single Immunization of Ad26.RSV.preF against RSV Infection in a Viral Challenge Model in Healthy Adults
2019
Transmission of Clonal Hepatitis C Virus Genomes Reveals the Dominant but Transitory Role of CD8+T Cells in Early Viral Evolution
2011
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
2010
Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection
2012